483 David O'Malley Jan 2018

483 David O'Malley Jan 2018

Geoffrey Kilili FDA$119.00 - Available Now

FDA investigators audited the David O'Malley - Hilliard, OH, United States facility and issued inspectional observations (via FDA 483) on 23 Jan 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 23 Jan 2018
  • Location: Hilliard, United States
  • FEI: 3013976843
Add To Cart